Cryosite logo

CTE - Cryosite Share Price

A$0.054 0.0  0.0%

Last Trade - 06/12/19

Sector
Healthcare
Size
Micro Cap
Market Cap £1.31m
Enterprise Value £-722k
Revenue £4.14m
Position in Universe 1708th / 1825
Bullish
Bearish
Unlock CTE Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CTE Revenue Unlock CTE Revenue

Net Income

CTE Net Income Unlock CTE Revenue

Normalised EPS

CTE Normalised EPS Unlock CTE Revenue

PE Ratio Range

CTE PE Ratio Range Unlock CTE Revenue

Dividend Yield Range

CTE Dividend Yield Range Unlock CTE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CTE EPS Forecasts Unlock CTE Revenue
Profile Summary

Cryosite Limited is a biotechnology and biologics logistics company. The Company is engaged in cryopreservation and expansion of mesenchymal stem cells (MSCs) from umbilical cord tissue. The Company operates through two segments: Individualised Consumer Biologics, and Scientific Processing and Logistics. The Individualised Consumer Biologics segment provides cord tissue MSC banking to parents, and specialized contract good manufacturing practice (GMP) manufacturing and associated consultancy services to therapeutic and regenerative medicine companies involved in the development and commercialization of technologies. The Scientific Processing and Logistics segment provides specialized commercial drug distribution. The Company also provides specialized bio-repository, clinical trials logistics, commercial drug distribution, contract cellular therapies manufacturing and associated consultancy services to commercial clients both within Australia and internationally.

Directors
Last Annual June 30th, 2019
Last Interim June 30th, 2019
Incorporated December 14, 1999
Public Since May 9, 2002
No. of Shareholders: n/a
No. of Employees: 34
Sector Healthcare
Industry Healthcare Providers & Services
Index
Exchange Australian Stock Exchange - SEATS
Shares in Issue 46,859,563
Free Float (0.0%)
Eligible for
ISAs
SIPPs
Address 13a Ferndell St, Lane Cove, 2142, Australia
Web https://cryosite.com
Phone +61 2 88652000
Contact ()
Auditors Mazars Risk & Assurance Pty Limited
CTE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CTE
Upcoming Events for CTE
Similar to CTE
© Stockopedia 2019, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.